| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.24 | 3e-07 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.22 | 2e-06 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.091 | 0.009 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |